Actively Recruiting

Phase Not Applicable
Age: 18Years - 85Years
All Genders
NCT05398003

Medullary Stimulation for the Treatment of Refractory Neck Pain (S2M)

Led by Nantes University Hospital · Updated on 2024-11-18

12

Participants Needed

1

Research Sites

200 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Number of centres planned : 1 (CHU Nantes) Design : Randomized, Prospective Planning of the study : * Total duration: 34 months * Recruitment period: 24 months. * Follow-up time per patients : 7-10 months Expected number of cases : 12 Treatment, procedure, combination of procedures under consideration : During the study, patients will be implanted with the WAVEWRITER ALPHA™ system with the objective of decreasing patient pain with a spinal cord stimulation mode. There will be a random draw on the order of the stimulation program: * the tonic stimulation "LF": In tonic mode, the electrical stimulation of the sensory fibers of the posterior cords of the spinal cord induces local paresthesias * burst stimulation (or "burst") * high frequency" stimulation (1000 Hz) "High frequency: HF". * combined tonic + burst stimulation * combined tonic + high frequency stimulation

CONDITIONS

Official Title

Medullary Stimulation for the Treatment of Refractory Neck Pain (S2M)

Who Can Participate

Age: 18Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 18 to 85 years
  • Patients with chronic neck and upper limb pain according to HAS criteria for spinal cord stimulation
  • Patients able to give informed consent and have signed an informed consent form
  • Affiliated to health insurance
  • Negative pregnancy test for women of childbearing potential
  • Women of childbearing potential must use appropriate contraception during the clinical trial
Not Eligible

You will not qualify if you...

  • History of drug or alcohol abuse
  • Any medical or psychological condition interfering with study protocol (e.g., cancer with limited life expectancy)
  • Difficulty with follow-up
  • Pregnant or breastfeeding women
  • Women of childbearing potential not using contraception
  • Adults under legal protection or deprived of liberty
  • Within exclusion period for another study
  • Participation in another interventional pain study
  • Negative 7-day post-implantation test phase

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

CHU de Nantes

Nantes, France, 44093

Actively Recruiting

Loading map...

Research Team

S

Sylvie RAOUL

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here